What is Dr. Reddy's Laboratories Limited's (DRREDDY.NS) StockRank?

MoatMap's StockRank for Dr. Reddy's Laboratories Limited (DRREDDY.NS) is 50/100, with a Hold signal. This is a composite score combining Quality (57), Value (37), and Momentum (50) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Dr. Reddy's Laboratories Limited have an economic moat?

Dr. Reddy's Laboratories Limited (DRREDDY.NS) has a Quality factor score of 57/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Dr. Reddy's Laboratories Limited a buy, hold, or sell?

MoatMap's current signal for Dr. Reddy's Laboratories Limited (DRREDDY.NS) is Hold, based on a StockRank of 50/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Dr. Reddy's Laboratories Limited in?

Dr. Reddy's Laboratories Limited (DRREDDY.NS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (India).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

DRREDDY.NS

HoldFallen Favourite

Dr. Reddy's Laboratories Limited · Healthcare · India · $10.1B · Avg Vol: $17M/d

StockRank

Get insider-trade alerts

P/E (TTM)

28.8x

ROE

8.8%

D/E

0.2x

Dividend %

0.7%

COMPANY DESCRIPTION

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment.

FINANCIAL SUMMARY (INR)

Year	2023	2024	2025	2026	CAGR	TTM	2027E	2028E	Fwd CAGR
Revenue	245.9B	279.2B	325.5B	335.9B	11.0%	332.3B	351.8B	392.7B	8.1%
EPS (INR)	54.28	67.04	67.88	51.48	-1.7%	39.85	41.53	55.10	3.5%
Shares	830.8M	832.6M	832.0M	832.7M	+0.2%	833.0M	—	—	—
Debt	13.5B	20.0B	46.8B	77.3B	79.1%	72.2B	—	—	—
Equity	231.0B	280.6B	333.4B	377.1B	17.7%	—	—	—	—
Op CF	58.9B	45.4B	46.4B	56.8B	-1.2%	41.3B	—	—	—
Inv CF	-41.4B	-40.3B	-58.1B	-65.5B	—	—	—	—	—
Fin CF	-26.9B	-3.8B	18.9B	8.3B	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+0.0%

SMA 50SMA 200

$12.00

RSI (14)

35.6

52W High

$14.73

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

11.0%74.0

ROE

8.8%66.9

GP/Assets

28.7%61.5

Op. Margin

4.3%50.8

FCF/Assets

1.6%53.1

Piotroski

431.0

Int. Cover

10.9x63.2

D/E Ratio

0.19x51.4

Current Ratio

1.90x36.7

Value

P/E (TTM)

28.8x41.2

EV/EBITDA

17.4x40.6

P/FCF

104.3x15.8

P/B

2.5x53.7

P/S

2.9x57.9

Div Yield

0.7%20.5

Momentum

52W High %

81%69.1

RS 6M

-9%54.4

SMA 50/200

0.96x46.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+49%54.3

Q Growth

-69%5.3

FUNDAMENTALS

Market Cap

$10.1B

P/E (Forward)

19.3x

Gross Margin

50.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of DRREDDY.NS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
DRREDDY.NS	Dr. Reddy's Laboratories Limited(you)	$10.1B	50	Hold
TORNTPHARM.NS	Torrent Pharmaceuticals Limited	$19.9B	52	Hold
MANKIND.NS	Mankind Pharma Limited	$10.1B	69	Buy
CIPLA.NS	Cipla Limited	$11.8B	68	Buy
ZYDUSLIFE.NS	Zydus Lifesciences Limited	$12.1B	68	Buy
WOCKPHARMA.NS	Wockhardt Limited	$3.8B	54	Hold
LAURUSLABS.NS	Laurus Labs Limited	$11.1B	75	Buy
ALKEM.NS	Alkem Laboratories Limited	$6.5B	69	Buy
PPLPHARMA.NS	Piramal Pharma Limited	$3.2B	58	Hold
NEULANDLAB.NS	Neuland Laboratories Limited	$3.2B	64	Hold

Peer medians: ROE 11.9% · P/E 43.0x · Gross margin 59.4%

Dr. Reddy's Laboratories Limited (DRREDDY.NS): Stock Score Summary

Dr. Reddy's Laboratories Limited (DRREDDY.NS) has a MoatMap StockRank of 50/100 based on Quality (57/100), Value (37/100), and Momentum (50/100) factor scores. The current signal is HOLD.

Key Financial Metrics

Price	$12.00
Market Cap	$10.1B
P/E (TTM)	28.83
P/E (Forward)	19.31
Price/Book	2.49
Return on Equity	8.8%
Return on Invested Capital	11.0%
Debt/Equity	0.19x
Gross Margin	50.2%
Operating Margin	4.3%
Revenue Growth	-5.6%
Dividend Yield	0.7%
Free Cash Flow	$97M

Dr. Reddy's Laboratories Limited operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (India).

Frequently Asked Questions

What is Dr. Reddy's Laboratories Limited’s (DRREDDY.NS) StockRank?: MoatMap’s StockRank for Dr. Reddy's Laboratories Limited (DRREDDY.NS) is 50/100, with a Hold signal. It is a composite of Quality (57), Value (37), and Momentum (50) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Dr. Reddy's Laboratories Limited have an economic moat?: Dr. Reddy's Laboratories Limited (DRREDDY.NS) has a Quality factor score of 57/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Dr. Reddy's Laboratories Limited a buy, hold, or sell?: MoatMap’s current signal for Dr. Reddy's Laboratories Limited (DRREDDY.NS) is Hold, based on a StockRank of 50/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Dr. Reddy's Laboratories Limited in?: Dr. Reddy's Laboratories Limited (DRREDDY.NS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (India).